文献速递生殖医学

接受卵母细胞捐赠女性黄体期每周肌注黄体酮与流产率降低相关

Weekly intramuscular progesterone for luteal phase support in women receiving oocyte donation is associated with a decreased miscarriage rate.
PubMed 文献 · Reprod Biomed Online · 2019-05-08

该回顾性分析纳入2016年1月至2018年5月186个卵母细胞捐赠周期,比较单用阴道黄体酮与加用每周肌注黄体酮(HCG阳性后加用或移植当晚加用)的流产率。移植当晚加用肌注黄体酮组流产率显著低于单用阴道组(16.7% vs 47.0%,Bonferroni校正后P=0.049),活产率更高(37.3% vs 16.0%,校正后P=0.009)。

要点

  • 移植当晚加用每周肌注黄体酮者流产率16.7%,单用阴道者47.0%。
  • 移植当晚加用肌注黄体酮者活产率37.3%,单用阴道者16.0%。
  • 三组间HCG阳性率、生化妊娠率及临床妊娠率无差异。

核心结论

  • 在卵母细胞捐赠中,阴道黄体酮加用肌注黄体酮似乎可降低流产率并提高活产率。
  • 移植当晚开始肌注黄体酮的获益最大。

研究设计与样本

  • 回顾性分析2016年1月至2018年5月的186个卵母细胞捐赠周期,胚胎移植日为第2天或第3天。
  • 受体经激素替代治疗准备子宫内膜,黄体支持为单用阴道黄体酮(106个周期)、HCG检测阳性后加用每周肌注黄体酮(29个周期)或移植当晚加用每周肌注黄体酮(51个周期)。

主要发现

  • 三组间HCG阳性率、生化妊娠率和临床妊娠率无差异。
  • 移植当晚加用肌注黄体酮组流产率16.7%,低于单用阴道黄体酮组的47.0%(Bonferroni校正后P=0.049)。
  • 移植当晚加用肌注黄体酮组活产率37.3%,高于单用阴道黄体酮组的16.0%(Bonferroni校正后P=0.009)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: To determine whether adding intramuscular to vaginal administration of progesterone reduces miscarriage rates compared with those of vaginal administration alone for luteal phase support in women receiving oocyte donation and to determine the best time to introduce intramuscular progesterone. DESIGN: Retrospective analysis of miscarriage rates in women receiving oocyte donation. Recipients underwent endometrial preparation by hormone replacement treatment. Vaginal progesterone alone or associated with intramuscular progesterone was used for luteal support. RESULTS: This study analysed 186 oocyte donation cycles from January 2016 to May 2018 with embryo transfer on Day 2 or 3 and vaginal progesterone administration: 106 embryo transfer cycles with vaginal progesterone alone, 29 with weekly intramuscular progesterone added once the human chorionic gonadotrophin (HCG) assay was positive, and 51 with weekly intramuscular progesterone added the evening of embryo transfer. The rates of positive HCG assays, biochemical pregnancies and clinical pregnancies did not differ between the treatment groups. The miscarriage rate was significantly lower when intramuscular progesterone began the evening of embryo transfer than with vaginal administration alone (16.7% versus 47.0%, respectively; P = 0.049 after Bonferroni correction). The live birth rate was higher when intramuscular progesterone began the evening of embryo transfer than with vaginal administration alone (37.3% versus 16.0%, respectively; P = 0.009 after Bonferroni correction). CONCLUSIONS: Adding intramuscular to vaginal progesterone administration appears to decrease the miscarriage rate and increase the live birth rate in oocyte donations. The initiation of intramuscular progesterone is most beneficial when it is introduced the evening of embryo transfer.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Delcour C, Robin G, Delesalle AS, et al. Weekly intramuscular progesterone for luteal phase support in women receiving oocyte donation is associated with a decreased miscarriage rate. Reprod Biomed Online. 2019. PMID: 31311693. doi:10.1016/j.rbmo.2019.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。